Literature DB >> 29602753

Ivermectin: repurposing an old drug to complement malaria vector control.

N Regina Rabinovich1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29602753     DOI: 10.1016/S1473-3099(18)30176-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Using the human blood index to investigate host biting plasticity: a systematic review and meta-regression of the three major African malaria vectors.

Authors:  James Orsborne; Luis Furuya-Kanamori; Claire L Jeffries; Mojca Kristan; Abdul Rahim Mohammed; Yaw A Afrane; Kathleen O'Reilly; Eduardo Massad; Chris Drakeley; Thomas Walker; Laith Yakob
Journal:  Malar J       Date:  2018-12-18       Impact factor: 2.979

Review 2.  Drug targets for COVID-19 therapeutics: Ongoing global efforts.

Authors:  Ambrish Saxena
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds.

Authors:  Awet Alem Teklemichael; Shusaku Mizukami; Kazufumi Toume; Farhana Mosaddeque; Mohamed Gomaa Kamel; Osamu Kaneko; Katsuko Komatsu; Juntra Karbwang; Nguyen Tien Huy; Kenji Hirayama
Journal:  Malar J       Date:  2020-06-08       Impact factor: 2.979

4.  A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.

Authors:  Peter Billingsley; Fred Binka; Carlos Chaccour; Brian Foy; Silvia Gold; Matiana Gonzalez-Silva; Julie Jacobson; George Jagoe; Caroline Jones; Patrick Kachur; Kevin Kobylinski; Anna Last; James V Lavery; David Mabey; David Mboera; Charles Mbogo; Ana Mendez-Lopez; N. Regina Rabinovich; Sarah Rees; Frank Richards; Cassidy Rist; Jessica Rockwood; Paula Ruiz-Castillo; Jetsumon Sattabongkot; Francisco Saute; Hannah Slater; Andrew Steer; Kang Xia; Rose Zullinger
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.